Emcure Pharma names RS Vasan as President - India Business

Published On 2025-07-14 08:00 GMT   |   Update On 2025-07-14 09:21 GMT
Advertisement

PuneEmcure Pharma has announced the appointment of R.S. Vasan as President - India Business and Senior Management Personnel of the Company.

"We would like to inform that upon recommendation of Nomination and Remuneration Committee, the Board of Directors vide its resolution passed by circulation dated July 14, 2025, has appointed Mr. R.S. Vasan as President – India Business and Senior Management Personnel (“SMP”) of the Company w.e.f. July 14, 2025, as per Regulation 16(1)(d) of SEBI Listing Regulations," Emcure stated in a BSE filing.

R.S. Vasan has over 40 plus years of experience in Pharmaceuticals Industry and has held various senior leadership positions. Prior to joining Emcure, he was associated with Sun Pharma for more than 15 years and has previously held senior roles at other Pharma Companies.

Vasan holds a PG in Management from Macquarie Graduate School of Management, Sydney, Australia and is an alumnus of IIM Ahmedabad, IIM Bangalore & ISB Hyderabad. He is also a Rank Holder in Master of Science in Organic Chemistry.

Read also: Emcure Pharma European arm Tillomed buys strategic pharma portfolio from Manx for 19.7 million pounds

Medical Dialogues team reported in June the resignation of Anil Kothiyal, President - India Sales & Marketing and Senior Management Personnel of the Company, effective from close of business hours on June 06, 2025, due to personal reasons.

Read also: Emcure Pharma Anil Kothiyal to resign as President - India Sales & Marketing

Established in 1981, Emcure Pharmaceuticals Ltd. is an Indian pharma company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Emcure is an R&D driven company that develops and manufactures a wide range of differentiated pharmaceutical products designed to improve patient health and well-being across several major therapeutic areas. Emcure is present in 70+ countries globally including Europe and Canada.

Read also: Emcure Pharma incorporates new wholly-owned subsidiary Emcure Wellness

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News